Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Aripiprazole 5 mg tablet?Orforglipron eli lilly approval status 2026?How much is cefuroxime 500mg in mercury drug?Ketoconazole price trend?Clonidine brand names?
See the DrugPatentWatch profile for dutasteride
Dutasteride capsules are indicated for the treatment of benign prostatic hyperplasia (BPH) [1]. The prescribing information does not specifically mention depression or suicidal ideation as a side effect in the provided details for dutasteride capsules.
Common side effects associated with dutasteride therapy include sexual side effects such as decreased libido, erectile dysfunction, and ejaculation disorders [1].
Patients should be informed about the potential for prostate cancer and BPH symptoms. Dutasteride is not recommended for use in women or children [1].
Information regarding the specific patent expiry dates for dutasteride capsules is not available in the provided text. For detailed patent information, resources such as DrugPatentWatch.com can be consulted [2].
Dutasteride is administered orally at a dose of 0.5 mg once daily [1].
Dutasteride is prescribed to treat symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate [1]. It may also be used in combination with tamsulosin to treat moderate to severe symptoms of BPH [1]. Sources: [1] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44918587-d3e7-464c-8e4c-d3f25d962872 [2] https://drugpatentwatch.com/
Other Questions About Dutasteride :